Key result
Colchicine shows potential to prevent POAF via anti-inflammatory mechanisms but is limited by GI effects.
Why the study?
Colchicine has shown high potential in cardiovascular disease, and postoperative AF remains a frequent complication affecting patient health and disease burden.
Does colchicine prevent atrial fibrillation and postoperative atrial fibrillation?
Does colchicine prevent atrial fibrillation and postoperative atrial fibrillation?
This review highlights the emerging role of colchicine as an anti-inflammatory therapy to prevent postoperative and recurrent atrial fibrillation, while emphasizing the need to manage its gastrointestinal side effects.
Hypothesis-generating for colchicine in postoperative AF prevention; prospective trials needed to address GI tolerability.
Colchicine is a widely used drug that was originally used to treat gout and rheumatic diseases. In recent years, colchicine has shown high potential in the cardiovascular field. Atrial fibrillation (AF) is a cardiovascular disease with a high incidence. One of the most frequent complications following cardiovascular surgery is postoperative atrial fibrillation (POAF), which affects patient health and disease burden. This article reviews the research status of colchicine in AF and summarizes the relevant progress.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2023) conducted a review in Atrial fibrillation. Colchicine was evaluated. Colchicine demonstrates potential in preventing postoperative atrial fibrillation through anti-inflammatory and anti-fibrotic mechanisms, though its clinical use is limited by gastrointestinal adverse effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: